Safety & Performance Study of Verruca Treatment Device

Inclusion criteria

• Male or female patients aged >18 years
• Patients with verrucas
• Patients should be willing to take part, able to understand the information given to them and give written consent

Exclusion criteria

• Patient with more than two areas affected by verrucas on one foot
• Patient who are actively treating or have treated their wart within the past 8 weeks
• Patient suspected to be immunocompromised or are taking immunosuppressants
• Patient who suffer from impaired feeling due to diabetes, peripheral vascular disease or neuropathy.
• Current participation in another clinical investigation or participation within the last 30 days.
• Patient with known sensitivity/allergies to the test materials or any of their ingredients.
• Significant current or past medical history of hepatic, renal, cardiac, pulmonary, digestive, haematological, neurological, locomotor or psychiatric disease, which, in the opinion of the Investigator, would compromise the safety of the volunteer or affect the outcome of the investigation (as determined from self-reported medical history questionnaire).
• Patient in a situation which in the view of the investigator could interfere with optimal participation in the investigation or constitute a special risk for these patients.
• Patient who scar easily or are prone to hypertrophic or Keloid scarring.
• Patient who have previously had an unfavourable reaction to any products for the feet and which involved swelling of the foot, or a requirement for painkillers or antibiotics.
• Pregnant and lactating females, or those actively seeking to become pregnant in the next month